REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 27, 2015
Insider Transaction Report
Form 4
Ahn Chang Ho
DirectorChairman & CEO
Transactions
- Award
Stock Option (right to purchase)
2015-01-23+333,332→ 333,332 totalExercise: $0.71Exp: 2025-01-23→ Common Stock (333,332 underlying)
Footnotes (1)
- [F1]Options will vest and become exercisable based on the following schedule: 83,333 on January 23, 2016, 83,333 on January 23, 2017, 83,333 on January 23, 2018, and 83,333 on January 23, 2019.